搜索临床试验以:NCX 470 0.1%
总计14868个结果
-
Athira PharmaBiotrial Inc.; Alzheimer's Drug Discovery Foundation完全的
-
OmicsWay Corp.Oncobox Ltd; Vitamed LLC; N.N. Blokhin National Medical Research Center of Oncology; Kaluga Regional... 和其他合作者主动,不招人
-
Ceylan SaygiliIstanbul University - Cerrahpasa (IUC)完全的
-
AptinyxCogState Ltd.; Worldwide Clinical Trials主动,不招人
-
National Cancer Institute (NCI)完全的
-
Cryonove PharmaCEISO; Dermatech; Sefako Makgatho Health Sciences University完全的
-
Alliance PharmaceuticalsSouth Florida Family Health and Research Centers招聘中
-
University of HelsinkiFinnish Cultural Foundation; University of Oulu; Finnish Work Environment Fund; Juho Vainio Foundation 和其他合作者未知
-
Laboratorios Sophia S.A de C.V.完全的
-
AptinyxMassachusetts General Hospital; Premier Research Group plc完全的
-
CytomX Therapeutics完全的肿瘤 | 乳腺癌 | 乳腺肿瘤 | 乳腺肿瘤,三阴性 | 乳腺肿瘤,激素受体阳性/HER2 阴性美国, 西班牙, 大韩民国
-
Hospices Civils de Lyon完全的
-
Stem Cell Therapeutics Corp.终止
-
UNC Lineberger Comprehensive Cancer CenterNational Institute of Nursing Research (NINR)完全的